Orroth K - Search Results

1

Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US.

Joshi PH, Marcovina S, Orroth K, López JAG, Kent ST, Kaplan R, Swett K, Sotres-Alvarez D, Thyagarajan B, Slipczuk L, Sofer T, Daviglus ML, Talavera GA, Schneiderman N, Rodriguez CJ. Joshi PH, et al. Among authors: orroth k. JAMA Cardiol. 2023 Jul 1;8(7):691-696. doi: 10.1001/jamacardio.2023.1134. JAMA Cardiol. 2023. PMID: 37223894

2

Characteristics of patients with diabetes and a history of myocardial infarction initiating PCSK9 and SGLT2 inhibitors.

Hubbard D, McKinley EC, Colantonio LD, Poudel B, Rosenson RS, Brown TM, Jackson EA, Huang L, Orroth KK, Mues KE, Dluzniewski PJ, Bittner V, Muntner P. Hubbard D, et al. Among authors: orroth kk. Am Heart J Plus. 2022 Mar 24;13:100121. doi: 10.1016/j.ahjo.2022.100121. eCollection 2022 Jan. Am Heart J Plus. 2022. PMID: 38560067 Free PMC article.

3

Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population.

Horner ME, Orroth KK, Ma J, Duan Y, Cordey M. Horner ME, et al. Among authors: orroth kk. Dermatol Ther (Heidelb). 2024 Jan;14(1):187-199. doi: 10.1007/s13555-023-01065-0. Epub 2024 Jan 12. Dermatol Ther (Heidelb). 2024. PMID: 38216820 Free PMC article.

4

Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.

Das AK, Chang E, Paydar C, Broder MS, Orroth KK, Cordey M. Das AK, et al. Among authors: orroth kk. Dermatol Ther (Heidelb). 2023 Sep;13(9):1973-1984. doi: 10.1007/s13555-023-00967-3. Epub 2023 Jul 1. Dermatol Ther (Heidelb). 2023. PMID: 37392261 Free PMC article.

5

Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.

Das AK, Chang E, Paydar C, Broder MS, Orroth KK, Cordey M. Das AK, et al. Among authors: orroth kk. Dermatol Ther (Heidelb). 2023 Sep;13(9):1985. doi: 10.1007/s13555-023-00984-2. Dermatol Ther (Heidelb). 2023. PMID: 37482565 Free PMC article. No abstract available.

6

Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.

Zheutlin AR, Derington CG, Herrick JS, Rosenson RS, Poudel B, Safford MM, Brown TM, Jackson EA, Woodward M, Reading S, Orroth K, Exter J, Virani SS, Muntner P, Bress AP. Zheutlin AR, et al. Among authors: orroth k. Circ Cardiovasc Qual Outcomes. 2022 Dec;15(12):e008861. doi: 10.1161/CIRCOUTCOMES.121.008861. Epub 2022 Oct 14. Circ Cardiovasc Qual Outcomes. 2022. PMID: 36252093 Free PMC article.

7

Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.

Levintow SN, Orroth KK, Breskin A, Park AS, Flores-Arredondo JH, Dluzniewski P, Navar AM, Sørensen HT, Brookhart MA. Levintow SN, et al. Among authors: orroth kk. Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):383-392. doi: 10.1002/pds.5396. Epub 2021 Dec 20. Pharmacoepidemiol Drug Saf. 2022. PMID: 34894377

8

Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction.

McKinley EC, Bittner VA, Brown TM, Chen L, Colantonio LD, Exter J, Orroth KK, Reading SR, Rosenson RS, Muntner P. McKinley EC, et al. Among authors: orroth kk. J Clin Lipidol. 2022 Jan-Feb;16(1):75-82. doi: 10.1016/j.jacl.2021.11.001. Epub 2021 Nov 7. J Clin Lipidol. 2022. PMID: 34848176

9

The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.

McKinley EC, Bittner VA, Brown TM, Chen L, Exter J, Farkouh ME, Huang L, Jackson EA, Levitan EB, Orroth KK, Reading SR, Rosenson RS, Safford MM, Woodward M, Muntner P, Colantonio LD. McKinley EC, et al. Among authors: orroth kk. Cardiovasc Drugs Ther. 2023 Feb;37(1):107-116. doi: 10.1007/s10557-021-07268-x. Epub 2021 Oct 2. Cardiovasc Drugs Ther. 2023. PMID: 34599698

10

Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.

Hess CN, Cannon CP, Beckman JA, Goodney PP, Patel MR, Hiatt WR, Mues KE, Orroth KK, Shannon E, Bonaca MP. Hess CN, et al. Among authors: orroth kk. J Am Coll Cardiol. 2021 Jun 22;77(24):3016-3027. doi: 10.1016/j.jacc.2021.04.060. J Am Coll Cardiol. 2021. PMID: 34140105 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page